| Column Group IV GP, LP | 10% Owner | 89,200Common Stock | $979.4K | Buy | |
|---|
| Bowie Alfred Lloyd Jr. | Chief Financial Officer | 67,044Stock Option (Right to Buy) | $923.9K | Grant / award | |
|---|
| Baynes Roy D. | Chief Medical Officer | 134,088Stock Option (Right to Buy) | $1.8M | Grant / award | |
|---|
| Thorner Benjamin Bruno | See Remarks | 67,044Stock Option (Right to Buy) | $923.9K | Grant / award | |
|---|
| PERLMUTTER ROGER M | See remarks | 268,176Stock Option (Right to Buy) | $3.7M | Grant / award | |
|---|
| FRAZIER KENNETH C | Director | 25,873Stock Option (Right to Buy) | $356.5K | Grant / award | |
|---|
| Huffines Robert Luther | Director | 25,873Stock Option (Right to Buy) | $356.5K | Grant / award | |
|---|
| Klobuchar Michael A | Chief Operating Officer | 87,157Stock Option (Right to Buy) | $1.2M | Grant / award | |
|---|
| PERLMUTTER ROGER M | See remarks | 284,857Common Stock | $4.1M | Conversion | |
|---|
| Column Group IV GP, LP | 10% Owner | 2,117,760Common Stock | $30.7M | Buy | |
|---|
